DK135131C - Analogifremgangsmade til fremstilling af 6alfa,16alfa-dimethyl-1,4-pregnadien-3,20-dioner - Google Patents

Analogifremgangsmade til fremstilling af 6alfa,16alfa-dimethyl-1,4-pregnadien-3,20-dioner

Info

Publication number
DK135131C
DK135131C DK575371A DK575371A DK135131C DK 135131 C DK135131 C DK 135131C DK 575371 A DK575371 A DK 575371A DK 575371 A DK575371 A DK 575371A DK 135131 C DK135131 C DK 135131C
Authority
DK
Denmark
Prior art keywords
16alfa
6alfa
dioner
pregnadien
dimethyl
Prior art date
Application number
DK575371A
Other languages
Danish (da)
English (en)
Other versions
DK135131B (da
Inventor
K Kieslich
U Kerb
K Mengel
A Domenico
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of DK135131B publication Critical patent/DK135131B/da
Application granted granted Critical
Publication of DK135131C publication Critical patent/DK135131C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0023—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16
    • C07J5/003—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0095—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 carbon in position 21 is part of carboxylic group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/832—Bacillus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK575371A 1970-11-28 1971-11-24 Analogifremgangsmade til fremstilling af 6alfa,16alfa-dimethyl-1,4-pregnadien-3,20-dioner DK135131C (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2059310A DE2059310C3 (de) 1970-11-28 1970-11-28 diese enthaltende Arzneimittel sowie Verfahren zu ihrer Herstellung

Publications (2)

Publication Number Publication Date
DK135131B DK135131B (da) 1977-03-07
DK135131C true DK135131C (da) 1977-08-08

Family

ID=5789778

Family Applications (1)

Application Number Title Priority Date Filing Date
DK575371A DK135131C (da) 1970-11-28 1971-11-24 Analogifremgangsmade til fremstilling af 6alfa,16alfa-dimethyl-1,4-pregnadien-3,20-dioner

Country Status (23)

Country Link
US (1) US3828083A (OSRAM)
AR (1) AR193053A1 (OSRAM)
AT (1) AT312824B (OSRAM)
AU (1) AU3598871A (OSRAM)
BE (1) BE775901A (OSRAM)
CA (1) CA933915A (OSRAM)
CH (2) CH591518A5 (OSRAM)
CS (1) CS166787B2 (OSRAM)
DE (1) DE2059310C3 (OSRAM)
DK (1) DK135131C (OSRAM)
EG (1) EG10261A (OSRAM)
ES (1) ES395740A1 (OSRAM)
FI (1) FI49159C (OSRAM)
FR (1) FR2115437B1 (OSRAM)
GB (1) GB1377993A (OSRAM)
HU (1) HU162900B (OSRAM)
IE (1) IE35822B1 (OSRAM)
IL (1) IL38241A (OSRAM)
NL (1) NL7116335A (OSRAM)
RO (1) RO67639A (OSRAM)
SE (1) SE374109B (OSRAM)
SU (1) SU474141A3 (OSRAM)
ZA (1) ZA717489B (OSRAM)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2448662C2 (de) * 1974-10-09 1983-07-21 Schering Ag, 1000 Berlin Und 4619 Bergkamen 6α-Fluor-16α-methyl-1,4,8-pregnatrien-3,20-dion-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
US9198921B2 (en) 2010-04-05 2015-12-01 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-κB for treatment of disease

Also Published As

Publication number Publication date
US3828083A (en) 1974-08-06
GB1377993A (en) 1974-12-18
SE374109B (OSRAM) 1975-02-24
IL38241A0 (en) 1972-01-27
CA933915A (en) 1973-09-18
AR193053A1 (es) 1973-03-30
CS166787B2 (OSRAM) 1976-03-29
EG10261A (en) 1976-04-30
CH591518A5 (OSRAM) 1977-09-30
FR2115437B1 (OSRAM) 1975-04-18
PL74335B1 (OSRAM) 1974-10-30
ES395740A1 (es) 1973-12-01
SU440831A3 (OSRAM) 1974-08-25
SU474141A3 (ru) 1975-06-14
BE775901A (fr) 1972-03-16
AT312824B (de) 1974-01-25
IE35822B1 (en) 1976-05-26
ZA717489B (en) 1972-07-26
FR2115437A1 (OSRAM) 1972-07-07
AU3598871A (en) 1973-05-31
DK135131B (da) 1977-03-07
IL38241A (en) 1975-08-31
IE35822L (en) 1972-05-28
RO67639A (ro) 1982-10-26
FI49159B (OSRAM) 1974-12-31
FI49159C (fi) 1975-04-10
HU162900B (OSRAM) 1973-04-28
DE2059310B2 (de) 1980-03-06
CH617709A5 (OSRAM) 1980-06-13
NL7116335A (OSRAM) 1972-05-30
DE2059310A1 (de) 1972-06-08
DE2059310C3 (de) 1980-10-30

Similar Documents

Publication Publication Date Title
DK143799C (da) Fremgangsmaade til fremstilling af n-1,1,1-trisubstituerede methylazoler
DK132174C (da) Analogifremgangsmade til fremstilling af 2,4-diamino-5-benzylpyrimidiner
DK129339B (da) Analogifremgangsmåde til fremstilling af N-aminophenylamidiner.
DK135455B (da) Fremgangsmåde til fremstilling af 7-halogen-7-desoxythiolincosaminider.
DK560675A (da) Fremgangsmade til fremstilling af thiopyrimidinderivater
DK134489B (da) Fremgangsmåde til fremstilling af alkyl-7-desoxy-7(S)-substituerede-alfa-thiolincosaminider.
DK130467B (da) Fremgangsmåde til fremstilling af erythromycylaminer.
DK131875C (da) Fremgangsmade til fremstilling af uricase
DK132586C (da) Fremgangsmade til fremstilling af erythromycylaminer
DK127977B (da) Fremgangsmåde til fremstilling af 6α-methyl-19-nor-pregnener.
DK128205B (da) Fremgangsmåde til fremstilling af 1-aryloxy-2-propanoler.
DK126323B (da) Fremgangsmåde til fremstilling af 3β-hydroxy-5α-cardenolider eller -bufadienolider.
DK129453B (da) Analogifremgangsmåde til fremstilling af 1-aminoisoquinoliner.
DK132831C (da) Analogifremgangsmade til fremstilling af 17beta-hydroxy-2,2,17-trimethyl-4-androsten-3-on
DK131786C (da) Fremgangsmade til fremstilling af delta4-3-oxo-1alfa-methylsteroider
DK140551B (da) Fremgangsmaade til fremstilling af diazabicycloalkanderivater
DK125388B (da) Fremgangsmåde til fremstilling af phenylaminoethanolderivater.
DK135131B (da) Analogifremgangsmade til fremstilling af 6alfa,16alfa-dimethyl-1,4-pregnadien-3,20-dioner
DK132121C (da) Fremgangsmade til fremstilling af 17alfa-hydroxypregna-4,9(11)-dien-3,20-dion
DK139577C (da) Fremgangsmaade til fremstilling af des-phenylalaninb1-insulin
DK132760C (da) Analogifremgangsmade til fremstilling af 6,21-dihalogen-16alfa,17alfa-dihydroxy-pregna-4,6-dien-3,20-dioner
DK129138B (da) Fremgangsmåde til fremstilling af tuberactinomycin-N.
DK127852B (da) Analogifremgangsmåde til fremstilling af 22-substituerede cardenolidrhamnosider.
DK127414B (da) Analogifremgangsmåde til fremstilling af phenylhydrazider.
DK132283C (da) Analogifremgangsmade til fremstilling af 15-oxasteroider

Legal Events

Date Code Title Description
PBP Patent lapsed